A Worldwide Leader in Pharmaceutical Services Selects LabVantage’s SAPPHIRE™ BioBanking Solution for Its Global Laboratories

LabVantage today announced that one of the world's largest contract research organizations (CROs) has licensed LabVantage's SAPPHIRE™ BioBanking Solution. The company plans to initially implement SAPPHIRE for eight of its global laboratories and expects to roll it out to more laboratories over time. As a global CRO, the company provides clinical product development services and consulting on product safety and value. Its global central laboratories support all phases of clinical trials with a centralized network of laboratories across all of the major international markets.

This global CRO's requirements for biospecimen management were involved and unique given its network of global central laboratories. They mandated that the solution not only effectively receive, store, route, and ship both frozen and ambient specimens, but it must also seamlessly monitor and exchange process information with its existing, centralized customer business relationship management system. Additionally, the complexity of managing biospecimens is compounded by its need to track and bill for services rendered. The company's decision to partner with LabVantage was based on a number of key factors, most notably the comprehensive functionality in the SAPPHIRE BioBanking solution and LabVantage’s proven track record of implementing, deploying, and interfacing SAPPHIRE across a global network.

The company intends to deploy its biospecimen management system as a central application server and single database solution residing within its data center. It will leverage SAPPHIRE's multinationalization capabilities to power multi-site, multi-language access by its employees, partners, and customers around the globe. As they invest in systems and processes to support its expanding global specimen management needs, SAPPHIRE takes them beyond a typical Web-based solution with SAPPHIRE's zero footprint, thin-client architecture that dramatically lowers software maintenance requirements and reduces total cost of ownership.

"This leading CRO's selection of the SAPPHIRE BioBanking Solution bears out the value of our technology and is also a testament to our industry standing as an organization that can lead, manage, and deliver complex global projects," affirms Jim Aurelio, CEO & President of LabVantage. "They join a long list of high-profile, leading-edge organizations that have conducted intensive 'due diligence' on laboratory software and services, and concluded that LabVantage is the company with whom to partner."